Genetic polymorphisms of IL-6-174 and IL-10-1082 in full term neonates with late onset blood stream infections

Journal of Pediatric Infectious Diseases

Volumn 4, Issue 4, 2009, Pages 357-365

  Abdel Hady, Hesham ^a   El Naggar, Mohamed ^b   El Nady, Ghada ^b   Badr, Rawia ^b   El Daker, Medhat ^b  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Blood stream infection; Gram negative; IL 10; IL 6; Newborn; Polymorphism

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6;

ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; GENE AMPLIFICATION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 70350767369     PISSN: 13057707     EISSN: None     Source Type: Journal    
DOI: 10.3233/JPI-2009-0203     Document Type: Article

References (39)

1. B.J. Stoll, N. Hansen, A.A. Fanaroff et al., Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network, Pediatrics 110 (2002), 285-291.
2. K.N. Haque, M.A. Khan, S. Kerry, J. Stephenson and G. Woods, Pattern of culture-proven neonatal sepsis in a district general hospital in the United Kingdom, Infect Control Hosp Epidemiol 25 (2004), 759-764.
3. R. Bell, S.V. Glinianaia, J. Rankin, C. Wright, M.S. Pearce and L. Parker, Changing patterns of perinatal death, 1982-2000: A retrospective cohort study, Arch Dis Child Fetal Neonatal Ed 89 (2004), 531-536.
4. F.S. Collins, E.D. Green, A.E. Guttmacher and M.S. Guyer, US National Human Genome Research Institute. A vision for the future of genomics research, Nature 422 (2003), 835-847.
5. F. Stüber, Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy? J Am Soc Nephrol 12 (2001), 60-64.
6. B. Schlüter, B. König, U. Bergmann, F.E. Müller and W. König, Interleukin 6-a potential mediator of lethal sepsis after major thermal trauma: Evidence for increased IL-6 production by peripheral blood mononuclear cells, J Trauma 31 (1991), 1663-1670.
7. D. Fishman, G. Faulds, R. Jeffery et al., The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis, J Clin Invest 102 (1998), 1369-1376.
8. S. Kilpinen, J. Hulkkonen, X.Y. Wang and M. Hurme, The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults, Eur Cytokine Netw 12 (2001), 62-68.
9. B. Schlüter, C. Raufhake, M. Erren et al., Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis, Crit Care Med 30 (2002), 32-37.
10. A.M. Sutherland, K.R. Walley, S. Manocha and J.A. Russell, The association of interleukin 6 haplotype clades with mortality in critically ill adults, Arch Intern Med 165 (2005), 75-82.
11. T. Sfeir, D.C. Saha, M. Astiz and E.C. Rackow, Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock, Crit Care Med 29 (2001), 129-133.
12. A. Oberholzer, C. Oberholzer and L.L. Moldawer, Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug, Crit Care Med 30 (2002), 58-63.
13. S.Q. Latifi, M.A. O'Riordan and A.D. Levine, Interleukin-10 controls the onset of irreversible septic shock, Infect Immun 70 (2002), 4441-4446.
14. V. Kahlke, C. Dohm, T. Mees, K. Brötzmann, S. Schreiber and J. Schröder, Early interleukin-10 treatment improves survival and enhances immune function only in males after hemorrhage and subsequent sepsis, Shock 18 (2002), 24-28.
15. P.R. Lowe, H.F. Galley, A. Abdel-Fattah and N.R. Webster, Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients, Crit Care Med 31 (2003), 34-38.
16. B.M. Schaaf, F. Boehmke, H. Esnaashari et al., Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism, Am J Respir Crit Care Med 168 (2003), 476-480.
17. Q. Shu, X. Fang, Q. Chen and F. Stuber, IL-10 polymorphism is associated with increased incidence of severe sepsis, Chin Med J (Engl) 116 (2003), 1756-1759.
18. J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan and J.M. Hughes, CDC definitions for nosocomial infections, in: APIC Infection Control and Applied Epidemiology: Principles and Practice, R.N. Olmstead, ed., St Louis: Mosby, 1996, pp. A1-A20.
19. C. Perrey, S.J. Turner, V. Pravica, W.M. Howell and I.V. Hutchinson, ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms, Transpl Immunol 7 (1999), 127-128.
20. V. Pravica, C. Perrey, A. Stevens, J.H. Lee and I.V. Hutchinson, A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production, Hum Immunol 61 (2000), 863-866.
21. C. Härtel, C. Schultz, E. Herting and W. Göpel, Genetic association studies in VLBW infants exemplifying susceptibility to sepsis - recent findings and implications for future research, Acta Paediatr 96 (2007), 158-165.
22. C.L. Holmes, J.A. Russell and K.R. Walley, Genetic polymorphisms in sepsis and septic shock: Role in prognosis and potential for therapy, Chest 124 (2003), 1103-1115.
23. M.N. Bittar, J.A. Carey, J. Barnard et al., Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery, Heart Surg Forum 8 (2005), 140-145.
24. J.J. Tischendorf, E. Yagmur, D. Scholten et al., The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6, Int J Immunogenet 34 (2007), 413-418.
25. J. Michalek, P. Svetlikova, M. Fedora et al., Interleukin-6 gene variants and the risk of sepsis development in children, Hum Immunol 68 (2007), 756-760.
26. T. Sipahi, H. Pocan and N. Akar, Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis, Clin Appl Thromb Hemost 12 (2006), 47-54.
27. P. Ahrens, E. Kattner, B. Köhler et al., Genetic Factors in Neonatology Study Group. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants, Pediatr Res 55 (2004), 652-656.
28. M. Reiman, H. Kujari, E. Ekholm, H. Lapinleimu, L. Lehtonen and L. Haataja, Interleukin-6 polymorphism is associated with chorioamnionitis and neonatal infections in preterm infants, J Pediatr 153 (2008), 19-24.
29. R.J. Baier, J. Loggins and K. Yanamandra, IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants, BMC Med 4 (2006), 10-21.
30. W. Göpel, C. Härtel, P. Ahrens et al., Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants, Genes Immun 7 (2006), 65-68.
31. A. Treszl, I. Kocsis, M. Szathmari et al., Genetic variants of TNF-alpha, IL-1beta, IL-4 receptor alpha-chain, IL-6 and IL-10 genes are not risk factors for sepsis in low-birth-weight infants, Biol Neonate 83 (2003), 241-245.
32. M. Chauhan andW. McGuire, Interleukin-6 (-174C) polymorphism and the risk of sepsis in very low birth weightinfants: Meta-analysis, Arch Dis Child Fetal Neonatal Ed 93 (2008), 427-429.
33. P. Wang, P. Wu, M.I. Siegel, R.W. Egan and M.M. Billah, Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms, J Biol Chem 270 (1995), 9558-9563.
34. S.A. Stanilova, Z.T. Karakolev, G.S. Dimov et al., High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors, Intensive Care Med 31 (2005), 401-407.
35. D.M. Turner, D.M. Williams, D. Sankaran, M. Lazarus, P.J. Sinnott and I.V. Hutchinson, An investigation of polymorphism in the interleukin-10 gene promoter, Eur J Immunogenet 24 (1997), 1-8.
36. C. Perrey, V. Pravica, P.J. Sinnott and I.V. Hutchinson, Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: A technical report, Transpl Immunol 6 (1998), 193-197.
37. S.A. Stanilova, L.D. Miteva, Z.T. Karakolev and C.S. Stefanov, Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility, Intensive Care Med 32 (2006), 260-266.
38. J. Balding, C.M. Healy, W.J. Livingstone et al., Genomic polymorphic profiles in an Irish population with meningococcaemia: Is it possible to predict severity and outcome of disease? Genes Immun 4 (2003), 533-540.
39. S.C. Hoffmann, E.M. Stanley, E.D. Cox et al., Ethnicity greatly influences cytokine gene polymorphism distribution, Am J Transplant 2 (2002), 560-567.